Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (133)

2024

  1. Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

    Journal of Medicinal Chemistry, Vol. 67, Núm. 18, pp. 16533-16555

  2. EPI-SURVEY: Grade of Awareness Among Spanish Allergists, Hospital Pharmacists, and Pulmonologists of the Relevance of Bronchial Epithelium and Alarmins in the Pathogenesis and Management of Severe Asthma

    Journal of Investigational Allergology and Clinical Immunology, Vol. 34, Núm. 5, pp. 336-338

  3. High-Throughput Screening of Low-Bandgap Organic Semiconductors for Photovoltaic Applications: In the Search of Correlations

    Solar RRL, Vol. 8, Núm. 13

  4. Hybrid Nanoparticles: Ni and Au Decorated with [FeFe]-Hydrogenase Mimics

    ChemCatChem

  5. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  6. Reusable Colorimetric Biosensors on Sustainable Silk-Based Platforms

    ACS Applied Bio Materials, Vol. 7, Núm. 2, pp. 853-862

2023

  1. Photo-electrochromic salt composed by viologen cation and diarylethene anion derivatives

    Electrochemical Science Advances, Vol. 3, Núm. 5

2022

  1. EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 1, pp. 17-38

  2. Electrocarboxylation of Spiropyran Switches through Carbon-Bromide Bond Cleavage Reaction

    ChemElectroChem, Vol. 9, Núm. 8

  3. Membrane rigidity regulates E. coli proliferation rates

    Scientific Reports, Vol. 12, Núm. 1

  4. Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice

    Journal of Medicinal Chemistry, Vol. 65, Núm. 16, pp. 10956-10974

  5. Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial

    Cancers, Vol. 14, Núm. 10

  6. Self-contained and integral microbial fuel cells as portable and sustainable energy sources for low-power field devices

    Electronic Journal of Biotechnology, Vol. 57, pp. 44-51

  7. Spectroelectrochemical studies of electrochromic diarylethene ionic Liquids: From solution to ionogel based devices

    Microchemical Journal, Vol. 182

2021

  1. Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 45-58

  2. Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 59-70

  3. Electrochromogenic Detection of Live Bacteria Using Soluble and Insoluble Prussian Blue

    ACS Omega, Vol. 6, Núm. 46, pp. 30989-30997

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  5. Near-Field Imaging of Magnetic Complex Mode Volume

    ACS Photonics, Vol. 8, Núm. 5, pp. 1258-1263

  6. Reversibly Switchable Fluorescent Molecular Systems Based on Metallacarborane–Perylenediimide Conjugates

    Chemistry - A European Journal, Vol. 27, Núm. 1, pp. 270-280